Jinih M, Wang JH, Pfirrmann RW, O'Leary DP, et al. Evaluation of the Cytotoxic Effects of the Novel Antineoplastic Agent 1,4,5-Oxathiazinane-4,4-dioxide on Triple Negative Breast Cancer Cells. Anticancer Res 2021;41:2247-2256.
PMID: 33952451